Understanding the mechanisms of aromatase inhibitor resistance.
about
Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspectiveA Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer.Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancerBazedoxifene exhibits antiestrogenic activity in animal models of tamoxifen-resistant breast cancer: implications for treatment of advanced disease.Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells.Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells.Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition.Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancerp53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors.Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell deathNew cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane.Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancerCYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patientsThe role of S6K1 in ER-positive breast cancer.Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal womenmTORC1 directly phosphorylates and activates ERα upon estrogen stimulation.Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.Analgesic use and patterns of estrogen metabolism in premenopausal women.Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer.Phase I trial of the androgen receptor modulator CR1447 in breast cancer.IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking.Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines.Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.Acquired resistance to everolimus in aromatase inhibitor-resistant breast cancer.
P2860
Q26752834-F9CFA9FF-8994-4724-AC8A-7D0B266D04BDQ30355029-94F45CA1-4478-4F4D-B752-D177273C5EDBQ30408963-193C52C7-D65B-4A6E-AF57-53BA915DD1ECQ30413295-4999314F-3574-4770-9DEB-8E9CFE6AC6B4Q33591225-C087A411-C532-488E-9288-45D299AF059EQ33735221-E03501AD-D09F-4282-A2EB-BE0FF37F1C6DQ34486201-3D043F7A-6E16-451C-BD99-BFEB831F3121Q34499512-827ECAB6-00C3-454E-ADE4-E4A231E5603CQ35051755-A2D0982B-6D52-49E8-9E0B-F41028FC76B7Q35107727-60536125-81A5-4442-ACD6-82619E8EAF7CQ35168124-96058B81-AE98-4FF6-9F71-AAEB3ABF1C70Q35521281-9B560115-4B60-4166-B456-626776A9751FQ35974459-9F8EE723-0850-4628-9745-96924F935ACAQ36304094-F10F3516-5973-4DE8-A8AA-BF38E88FE84AQ36331426-219598E9-9C4B-4730-9F73-EB4ED292171EQ36512812-ACD45C31-48E9-4FD2-9B63-43DB359833A9Q36578211-34E3DC2F-3CCF-45A4-B035-2DD76CF4D34EQ36824033-1BED0C47-0B60-4DF8-B70C-3B6A2969664EQ36858723-32C2BB7E-2145-44E5-9380-6D73215F1557Q37025619-204E4413-35F5-4ED5-9709-B20BD730AE0EQ37686568-D9A79941-AE55-4ADB-8D1E-3F2974D35F3DQ37690655-8D6BE8BA-B617-49D4-8BED-00EC25D8DE65Q38374560-4CD052E8-566A-49E1-A941-33E8DE0F8EAFQ38621527-87E2B567-2A88-4813-A52A-009414861471Q38707618-30342DD0-0A46-4BDE-B5C5-D7462FB2D278Q39227889-12FDC1D2-27A9-4ABD-BA4C-CCA7C0D2A10BQ47730656-8BA29D4C-F750-4F4D-809E-51C04ECC142BQ49225849-359FE095-CCD6-4E56-BDE1-3E2DD870668CQ50467757-D47BB780-F315-461B-8D8D-B82CD5C50007Q53681633-053FA785-1878-4A65-811E-6B9D66A56CA1
P2860
Understanding the mechanisms of aromatase inhibitor resistance.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Understanding the mechanisms of aromatase inhibitor resistance.
@ast
Understanding the mechanisms of aromatase inhibitor resistance.
@en
type
label
Understanding the mechanisms of aromatase inhibitor resistance.
@ast
Understanding the mechanisms of aromatase inhibitor resistance.
@en
prefLabel
Understanding the mechanisms of aromatase inhibitor resistance.
@ast
Understanding the mechanisms of aromatase inhibitor resistance.
@en
P2860
P921
P356
P1476
Understanding the mechanisms of aromatase inhibitor resistance.
@en
P2093
William R Miller
P2860
P2888
P356
10.1186/BCR2931
P577
2012-01-19T00:00:00Z
P5875
P6179
1016196124